drugset / Trial / NCT00877032
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
RandomizedSingle-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine the safety and tolerability of RN6G in patients with dry, age-related macular degeneration.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RN6G | Unknown | 0.3 mg/kg | Intravenous |
| Subject | RN6G | Unknown | 40 mg/kg | Intravenous |